Use of imaging and diagnostic procedures after low dose computed tomography screening for lung cancer.
CONCLUSIONS: In general, imaging and rates of procedures after screening LDCT was low in this commercially insured population. PMID: 31521671 [PubMed - as supplied by publisher]
Contributors : Hee-Yeon Kim ; Hyonchol JangSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensGene expression profile in parental and cisplatin-resistant A549 cells
Conclusions: The limited number of relevant articles found in this review may suggest that an OCP for lung cancer is still in its preliminary stages across the broader health systems. Published on 2020-09-28 10:48:53
LUNG cancer does not usually produce any symptoms until the cancer has advanced. A persistent cough could signal the cancer if you have it for this length of time.
(University of Otago) Newly released study results present a strong case for lung cancer screening in New Zealand - particularly for Māori whose mortality rates are between three and four times higher than other ethnic groups.
(SingHealth) Drug shown to precisely target non-small cell lung cancer driven bymutations to gene RET. Majority of patients on trial experience shrinking tumours and live formore than a year without disease progression. National Cancer Centre Singapore, one of a handful of three Asian centres to participate in the trial, has implemented routine testing of the gene RET for all lung cancer patients. Findings published in high impact factor journal, New England Journal of Medicine.
In this study, we aimed to compare protocol compliance and toxic complications during adjuvant chemotherapy after intubated and nonintubated VATS lobectomies in non‐small cell lung cancer (NSCLC).MethodsWe retrospectively reviewed the medical records of 66, stage IB –IIIB NSCLC patients who underwent intubated or nonintubated VATS lobectomy and received adjuvant chemotherapy.ResultsA total of 38 patients (17 males, mean age 64 years) underwent conventional VATS and 28 (7 males; mean age 63 years) uniportal VATS NITS. Both groups had comparable demographic data, preoperative pulmonary function, and Ea...
Consolidative thoracic radiotherapy (TRT) has been shown to improve outcomes for patients with extensive stage small cell lung cancer (ES-SCLC). We hypothesized that the addition of ipilimumab (IPI) and nivolumab (NIVO) after TRT would improve outcomes for patients with ES-SCLC.
an Tang Purpose: The current study aims to explore the barriers for middle-aged Chinese to learn about and uptake low-dose computed tomography (LDCT) lung cancer screening. Methods: Data were collected via an online survey in December 2019. Final valid sample included 640 respondents, aged 40–60 years old, from 21 provinces of China. We performed multiple linear regressions to test the potential barriers to LDCT scan. Findings: Cost concerns, distrust in doctors, fears of disease, lack of knowledge, and optimistic bias are negatively associated with the intention to learn about and uptake LDCT scan. Implicati...
ConclusionsOur study unraveled novel molecular mechanisms regarding the regulation of tumor PD-L1 and provided a novel combination therapeutic strategy of SB-3CT and ICB therapy to enhance the efficacy of immunotherapy.